Tuesday, October 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Impressive Financial Results for Liberty Braves Group and Affiliated Entities in Q4 2023

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Pickleball sports
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On February 28, 2024, Liberty Braves Group (NASDAQ: BATRA) announced impressive fourth-quarter 2023 results. The company reported a GAAP EPS of $(0.52), with baseball revenue hitting $52.9 million and total revenue reaching $71.26 million. This exceeded analyst estimates by 25.02% and marked a significant 34.45% increase in sales compared to the same period last year.

Moreover, Liberty Media Corporation, the parent company of Liberty Braves Group, revealed its full-year 2023 financial results. The company reported a revenue of $8.95 billion, net income of $1.26 billion, and diluted EPS of $0.32, along with a full-year adjusted EBITDA of $2.79 billion.

Atlanta Braves Holdings, Inc., another affiliated entity, also shared its fourth-quarter and year-end 2023 financial results. Baseball revenue stood at $56.947 million, while mixed-use development revenue reached $14.312 million, highlighting the positive performance within the Liberty Media Corporation ecosystem.

Overall, the financial reports demonstrate strong growth and performance by Liberty Braves Group, Liberty Media Corporation, and related entities, surpassing market expectations in the fourth quarter of 2023.

BATRA Stock Price Update: February 28, 2024 – Analysis and Potential Buying Opportunity

On February 28, 2024, BATRA stock experienced a slight decrease in price, closing at $42.22. This marks a $0.09 drop from the previous market close, representing a 0.21% decrease in value. Additionally, in after-hours trading, the stock dropped another $0.02.

BATRA is still trading near the bottom of its 52-week range, suggesting that the stock may be undervalued compared to its historical performance. Furthermore, BATRA is currently trading above its 200-day simple moving average, indicating some stability in the longer term.

Investors may see these price movements as a potential buying opportunity, especially if they believe in BATRA’s strong fundamentals and growth prospects. It is important to conduct thorough research and analysis before making any investment decisions.

Overall, BATRA’s performance on February 28, 2024, reflects a modest decline in price but also highlights the stock’s position relative to its historical range and moving average. Investors should continue to monitor BATRA’s performance and market conditions to make informed decisions about their investment strategies.

BATRA Stock Performance Analysis: Mixed Results on February 28, 2024

On February 28, 2024, BATRA stock showed mixed performances in terms of financial metrics. According to data from CNN Money, the company reported a total revenue of $588.56 million for the past year, which represented a 3.62% increase compared to the previous year. However, the total revenue remained flat at $271.82 million for the last quarter. BATRA reported a net loss of $34.17 million for the past year, which marked a significant decrease of 210.65% compared to the previous year. On a positive note, the net loss decreased by 79.09% to $6.05 million for the last quarter. Earnings per share (EPS) also showed a declining trend for BATRA stock. The company reported an EPS of -$0.55 for the past year, reflecting a decrease of 161.8% compared to the previous year. However, the EPS increased by 79.08% to -$0.10 for the last quarter. Overall, BATRA stock exhibited a mix of positive and negative trends in its financial performance on February 28, 2024. Investors and analysts will likely closely monitor the company’s future financial reports to assess its growth prospects and profitability potential.

Tags: BATRA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Ecommerce Stock Market Today

Coupang Reports Impressive Financial Performance for Q4 2023

Ecommerce Stock Exchange

eBays Stock Soars After Exceeding Q4 Expectations

Healthcare cloud based

Progyny Inc Q4 Financial Results Profitable Quarter with Revenue Miss

Recommended

Kopin Stock

Kopin Appoints New Finance Chief Amid Strategic Pivot

2 months ago
Benchmark Electronics Stock

Benchmark Electronics Navigates Mixed Quarter as Tax Charges Offset Record Orders

2 months ago
Agnc Investment Stock

AGNC Investment’s Dividend Sustainability Under Scrutiny Amid Rate Pressures

2 months ago
Adesso Stock

Adesso Stock: Strong Q2 Results Spark Rally

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Centrus Energy Shares Signal Potential Market Reversal

Acquisition Battle Intensifies for Warner Bros. Discovery

First Solar Shares Continue Their Record-Breaking Ascent

Tech Stocks Soar as Nasdaq 100 Reaches Unprecedented Peak

Cintas Shares: Strong Fundamentals Meet Market Skepticism

US Government Considers Strategic Investment in Quantum Computing Firm Rigetti

Trending

Sarepta Therapeutics Stock
Analysis

Sarepta Therapeutics Faces Critical Earnings Test Amid Regulatory Uncertainty

by Felix Baarz
October 28, 2025
0

Investors in Sarepta Therapeutics are approaching the company's upcoming quarterly report with heightened anticipation. The biotech firm's...

aTyr Pharma Stock

Biotech Firm aTyr Pharma Faces Investor Lawsuits Following Clinical Trial Setback

October 28, 2025
Amgen Stock

Amgen’s Pivotal Moment: Legal Win Sets Stage for Critical Earnings Report

October 28, 2025
Centrus Energy Stock

Centrus Energy Shares Signal Potential Market Reversal

October 28, 2025
Warner Bros. Discovery (A) Stock

Acquisition Battle Intensifies for Warner Bros. Discovery

October 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sarepta Therapeutics Faces Critical Earnings Test Amid Regulatory Uncertainty
  • Biotech Firm aTyr Pharma Faces Investor Lawsuits Following Clinical Trial Setback
  • Amgen’s Pivotal Moment: Legal Win Sets Stage for Critical Earnings Report

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com